.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The National Medical Commission (NMC) has issued a crucial public notice regarding an MBBS Admission Deadline Extension for the academic year 2025-26. Medical colleges across India now have an extended period to submit the details of their admitted first-year MBBS students on the NMC portal. This extension is a significant update for all concerned institutions, therefore ensuring compliance is paramount.
According to the latest circular (No. U-16011/Circular/2025-26/UGMEB/M.Cell dated 12-03-2026), the deadline for submitting the details of first-year MBBS students for the 2025-26 academic session has been extended. Originally, the last date was January 31, 2026, as per a previous circular dated 21-01-2026.
However, due to various representations and observations of incomplete submissions from several medical colleges, the competent authority decided to grant a further extension. Consequently, the new last date to fill up these crucial details on the Admission Portal is now **March 31, 2026 (midnight)**. This provides institutions additional time to finalize their submissions.
The NMC received numerous requests to reopen the portal to facilitate the submission of complete student details. Therefore, the commission decided to extend the deadline. This proactive step helps medical colleges comply with regulatory requirements, subsequently ensuring transparency in the MBBS admission process for the academic year.
The submission of MBBS admission data is mandatory. It falls under the “Criteria for Identification of Students Admitted in Excess of Admission Capacity of Medical College Regulations, 1997.” Furthermore, this process aligns with various directions issued by the Hon'ble Supreme Court of India. Ultimately, these measures ensure proper monitoring and transparency in medical admissions.
All concerned Medical Colleges and Institutions are explicitly requested to submit the requisite details as per the prescribed schedule. They must navigate the online portal via the link provided in the enclosed notice (https://www.nmc.org.in/ActivitiWebClient/login). Institutions must ensure the uploaded information is accurate, complete, and submitted within this revised timeline.
The NMC has emphasized that this extension should be considered the *final opportunity* for institutions to provide the necessary information. Therefore, no further extension for the submission of student details will be granted under any circumstances. Timely compliance is essential to avoid regulatory action and to safeguard the academic future of admitted students. You can find more updates on the official NMC website.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
NMC extends the deadline for 1st Year MBBS admission details for the 2025-26 academic year. Submit student information by March 31, 2026....
7 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
